TP53 and cancer: Webster et al. identified a positive feedback loop between p53 and non-canonical Wnt signaling in melanoma, showing that high WNT5A levels could stabilize wild-type p53 and increase its half-life, thus generating a slow-cycling, therapy-resistant cancer phenotype [129].